Search results for: Precision Medicine
Filter search results
Our Contributions to the Economics of Personalised Medicine
7 March 2018
…feasibility of genomics-guided precision medicine in the clinic. Journal of Personalised Medicine, 5(4), 354-369. DOI | PubMed To find more about our research on Personalised Medicine, click here. …
Adrian Towse named 2018 Value Assessment Challenge Award Recipient
22 October 2018
…Development and Use of innovations in Personalized and Precision Medicine,” Garrison and Towse call for a broadening of the concepts of value in personalized/precision medicine, laying out six basic policy…
Open Source Modelling: From Ideas to Action
16 May 2022
…has organised a Forum session titled Open Source In Precision Medicine: The Perfect Fit? Our goal with this session is to get real. We’ll discuss applied examples of open source…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…oncology demands precision medicine strategies at medical and non-medical level. Learning how to manage and mitigate uncertainties depending on the type of generated evidence is key. Reshaping the model of…
Personalised Medicine: Economic Incentives for Evidence Generation
28 October 2013
…of personalised, stratified or precision medicines include: Towse’s and Garrison’s contributions to the July 2013 Academy of Medical Sciences Report, Realising the potential of stratified medicines, available for download from…
Making Outcome-based Payments a Reality in the NHS: A Research Collaboration between OHE, RAND Europe and King’s College London
15 May 2018
…study of cancer outcomes and their potential linkage to payment arrangements. OHE’s team includes: Paula Lorgelly, who has expertise in the economics of cancer (e.g. survivorship, precision medicine and…
Reimagining Prevention for a Healthier, More Prosperous Society
12 October 2023
…for improvement include long-term cross-party agreement, innovative financing both within and outside NHS budgets (e.g., social impact bonds, dedicated prevention fund), and exploring new opportunities (precision medicine, digital health). Share…
OHE’s Towse on Challenges in Valuing Genomic Medicines
23 May 2013
In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” — those medicines that will allow targeted, precision…
Personalised Medicine: is it an Oil-Rush or Oil-Spill?
1 May 2020
Personalised medicine, also known as ‘precision’ or ‘stratified’ medicine, targets treatment by using genetics and/or biomarkers to identify patients or subgroups of patients who have distinct mechanisms of disease or…